Abstract
Heart diseases are the most common cause of death around the world. Therefore, it is important to develop new drugs and therapies, which can be useful in the treatment of cardiovascular diseases (CVDs). Elaboration of in vivo-like culture models of heart cells will allow the mimicking of native heart tissue and the investigation of heart cell response to the exposure of external stimuli. Heart-on-a-chip systems can be successfully used to imitate heart tissue functions and to perform assays based on cardiotherapy. In this chapter, we present Heart-on-a-chip systems, which can be utilized for various types of assays. Different cardiac cell cultures performed in Lab-on-a-chip systems are characterized at the beginning of this chapter. Single, monolayer , and spatial cell cultures are presented. Next, examples of cardiotoxicity assays and electrical stimulations performed in Heart-on-a-chip systems are described. Methods of heart cell analysis used in microscale are also defined. Finally, we summarize the research focused on Heart-on-a-chip systems and we outline perspectives for the usage of such microsystems.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
8.1 Cardiac Cell Cultures in Lab-on-a-chip Systems
Heart-on-a-chip systems are developed to create culture models, which are able to mimic functional heart tissue (Selimović et al. 2013). Such cellular models could lead to a better understanding of mechanisms responsible for heart diseases. In vivo-like cardiac cultures obtained in Lab-on-a-chip systems can be utilized for (1) the investigation of cardiac cell physiology under conditions close to in vivo, (2) the evaluation of the cardiotoxicity of drugs used for CVD therapy, (3) the investigation of side effects generated by different types of drugs, and (4) the study of mechanisms responsible for heart regeneration (Jastrzebska et al. 2016; Ribas et al. 2016; Zhang et al. 2016a, b).
Two-dimensional (2D) cell cultures (monolayers) are the most common in vitro models of the heart and cardiovascular system. However, they do not mimic the conditions present in a living organism accurately. Conventional cardiac cell cultures are based on a monolayer culture, where the cardiac cells are cultured on a flat surface of the culture flask. In this case, the culture is carried out under static conditions, where a culture medium is exchanged periodically (Ralphe and de Lange 2013). Additionally, the arrangement of the cells to each other is usually random in a conventional monolayer culture. The cells are arranged parallelly to each other in living organisms (Bhaarathy et al. 2014; LeGrice et al. 1995). It should be noted that such cell arrangement is essential in a cell model. The orientation of myocardial cells is determined by many factors. Mechanical factors play the most important role. In the native environment, heart tissue is constantly in contact with body fluids (blood, lymph) (Kujala et al. 2016). The continuous stimulation of heart cells by blood flow and physical forces in vivo (i.e., shear stress) is crucial for the determination of cardiac cell structure, phenotype, and alignment to the other cells. Therefore, the dynamic conditions should be provided to in vitro cardiac cell cultures. The Lab-on-a-chip systems are suitable tools, in which biochemical, mechanical, and physical factors of heart tissue can be mimicked (Chen et al. 2017; Giaseddin et al. 2017; Simmson et al. 2012). Key signaling parameters used to mimic native myocardium in the microsystems are described in detail in Chap. 7.
Heart and cardiovascular systems are composed of different cell types: e.g., cardiomyocytes (CMs), fibroblasts, endothelial cells, smooth muscle cells, and pericytes (see Chap. 5 and Fig. 8.1). CMs are myocardial cells, which are responsible for heart contractions. These cells have contractile proteins such as sarcomeres and myofibrils. Fibroblasts are responsible for producing an extracellular matrix (ECM) and the arrangement of other heart cells (Ugolini et al. 2016). Endothelial cells build heart atriums and produce atrial natriuretic peptide (ANP), which prevents heart failure (Maksimov et al. 2015). Pericytes build small blood vessels. Their function is very important, because they strengthen the blood vessels. Pericytes can also differentiate into other cells (fibroblasts or smooth muscle cells) depending on tissue requirements (Hall et al. 2014).
Cardiac and vascular cells are characterized as having a high dependency on the external environment (Conant et al. 2017). They exhibit morphological and physiological changes as a result of mechanical, biological, chemical, and electrical stimulations (Dahl et al. 2010; Simmson et al. 2012). CMs are the most commonly used for in vitro studies. Cardiomyoblasts (precursor of CMs) are the next cell type often utilized for in vitro experiments. Cardiomyoblasts are mesodermal cells, which can differentiate into transverse striated heart muscle cells (Simmson et al. 2012). The cells, utilized for in vitro assays, can be mainly derived from human, mouse, or rat. However, it should be noted that there are significant differences between human and animal cardiac cells. Rat CMs have a higher percentage of protein chains, which build filaments fibers (e.g., α-myosin) and a fivefold higher resting heart rate than human CMs. A calcium transport through the rat cell membrane is also carried out by other mechanism than in human cells. Mouse CMs differ from human heart cells even more than rat CMs. The resting heart rate of mouse CMs is tenfold higher than in human cells. Moreover, the way of potassium repolarization in mouse CMs is different than in human cardiac cells. This can influence the permeability of chemical compounds (e.g., drugs) through cell membranes. Finally, different drug cytotoxicity could be obtained depending on cell origin (Simmson et al. 2012). For this reason, stem cell-derived cardiomyocytes (SC-CMs) have been used for in vitro studies in recent years (Au et al. 2009). Human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSC) are predominantly differentiated in CMs using conventional methods (macroscale). Moreover, SC differentiation into CMs using different types of stimulation (biochemical, mechanical, and electrical) can be performed in microscale. These methods are described in detail in Chap. 9.
The Lab-on-a-chip systems used to create both a beating heart culture model and a whole vascular system have been presented in the literature in the last few years. Two-dimensional (2D) and three-dimensional (3D) cell cultures are obtained in the developed microsystems (Cheng et al. 2006; Ges et al. 2008; Horiguchi et al. 2009; Yue et al. 2014). A scheme of culture types, which can be obtained in Heart-on-a-chip systems, is shown in Fig. 8.2.
Poly(dimethyl siloxane) (PDMS) and glass are most commonly used for fabrication of Heart-on-a-chip systems. It results from the properties of these materials (see Chap. 3). It should be noted that PDMS is highly hydrophobic. 2D culture of CMs on PDMS surface is limited, because its hydrophobic properties inhibit cell attachment. In turn, a hydrophobic surface of PDMS enhances 3D cultures (spheroid formation). There are many physical and chemical methods, which can be used to increase PDMS hydrophilicity (Zuchowska et al. 2016). PDMS surfaces utilized for CM cultures are often modified by coating them with proteins such as collagen type I, fibronectin, laminin, or gelatin (Ugolini et al. 2016). The addition of proteins to the culture environment mimics a natural extracellular matrix (ECM). Moreover, proteins have an impact on the spatial organization of the CMs, their shape, contractility, and transport of calcium ions (Boudou et al. 2012). The culture surface can also be modified by changing the surface topography. For this purpose, the microgrooves with controlled depth and width are formed. Additionally, nano- and microfibers are used to change properties of the surface for CM cultures (Simmson et al. 2012; Tomecka et al. 2017). Modifications of culture surfaces are mainly carried out to stimulate anisotropic orientation of cardiac cells. Because of this, the cells can be parallelly arranged as in the native environment.
As was mentioned in the previous chapters, there are significant differences between 2D and 3D cultures. Both of them have important benefits and disadvantages to use. 3D cultures are similar to the in vivo microenvironment, whereas 2D cell models enable fast and precisely controlled analysis. A single-cell culture is considered to be a 2D culture. There are not physical and biochemical intercellular interactions in such a culture model. Single-cell culture is free of tissue-specific intercellular connections, intercellular spaces and gaps with natural ECM. The natural structure and morphology of the cytoskeleton are also not preserved in a single cell culture . However, the simplicity of such cultures allows for quick analysis of cell functions. It is possible to measure the contraction of a single cell. Kaneko et al. (2007) presented an interesting solution for single-cell analysis (Fig. 8.3a). The microplatform was composed of a glass plate with three layers: chromium, collagen type I, and agarose. Single cardiomyocytes isolated from 13- to 14-day-old mouse embryos were trapped into each microchamber fabricated in the agarose layer. Next, a CM contraction after introduction of haloperidol was measured using a microscope and a video image recording method. The results indicated that the direct single-cell-based measurement enabled precise and quantitative control of cytotoxic effects of the tested drug. The device for trapping a single cardiac myocyte and the measurement of pH in the extracellular environment was also presented in the literature (Ges et al. 2005, 2008). To trap a single cell, the microsystem was equipped with an integrated system of microchannels and microvalves. Each trapped cell was cultured in the microsystem for 1–2 h. Next, the influence of chemical compounds on cell physiology was studied based on the formation of metabolites (pH changes). The microsystem was made of a glass plate covered with a thin layer of two pH-sensitive iridium oxide (IrOx) electrodes and PDMS layer containing microstructures (Fig. 8.3b). Wild-type (WT) single CMs isolated from a mouse were tested in the microsystem. The proposed microsystem can be applied to study ischemia, reperfusion injury, or disorders of other biological systems.
2D monolayer culture is the next model often used to investigate CMs in microscale. Tanaka et al. (2007) have started research based on 2D cardiac cell culture in the microsystems. A microplatform (bio-microactuator) was made of PDMS using a replica molding technique. The microplatform consisted of a series of specific micropillars (10 µm high) designed for CM placement (Fig. 8.4a). Additionally, the PDMS surface was modified by fibronectin to enhance cell attachment to the micropillars. Primary neonatal rat CMs were cultured in the designed microplatform for 3 days. After that time, heart cell attachment to the micropillars and cell spontaneous beating was noticed. Cell contractions caused micropillar dilatation/deflection (1.4 Hz, ~3 µm displacement). The results showed that continuous cell-to-cell contacts and interactions indicated spontaneous and regular cardiac contraction without the use of any additional biochemical agents. The proposed bio-microactuator is a simplified type of an actuator, in which chemical energy generates mechanical energy (associated with cardiac muscle contractions).
To improve culture and beating of cardiomyocytes in the microsystems , the cells are exposed to additional factors. For example, methacrylated tropoelastin (MeTro) and methacrylated gelatin (GelMA) hydrogels were used for 2D CM cultures (Annabi et al. 2013). The cellular attachment, alignment, and beating of neonatal rat CMs cultured on the modified PDMS layers were compared. The obtained results indicated that PDMS coated with MeTro hydrogel had a high impact on cardiac cell proliferation. Moreover, this method of surface modification could be useful for the culture of other cell types derived from the cardiovascular system (e.g., blood vessel cells).
The cells in heart tissue are exposed to dynamic flow conditions and stretching. Therefore, it is important to mimic these features in the Heart-on-a-chip systems. The microsystems, in which perfusion conditions are simulated, were often presented in the literature (Chen et al. 2017; Kobuszewska et al. 2017; Kujala et al. 2016; Nguyen et al. 2015). It results from the fact that flow conditions play a critical role in the early development and functional maturation of CMs. Moreover, the flow affects cell organization, intercellular interactions, and the transmission of chemical and physical signals (e.g., responsible for contraction) (Mannhardt et al. 2017). For example, Kobuszewska et al. (2017) studied how the geometry of a microsystem and microenvironmental conditions (static and perfusion) influence the proliferation, morphology, and alignment of rat cardiomyoblasts—H9C2 cells. Three different microsystems with a circular chamber, a longitudinal channel, and three parallel microchannels separated by two rows of micropillars were used in the experiments. It was found that perfusion conditions enhanced cell proliferation and induced parallel arrangement of the cells more than static conditions. Additionally, it was observed that the parallel orientation and elongation of the cells are dependent on microchamber geometry.
Stimulation of the cells using two different external agents enhanced CM proliferation. The usage perfusion conditions and mechanical stimulation resulted in increasing of cardiac gene expression (e.g., α-actin sarcomere, cardiac troponin T) and protein synthesis for calcium transport. For example, Nguyen et al. (2015) presented a fully automated platform for 2D cell culture of the embryonic ventricular chick CMs (Fig. 8.4b). The cells were cultured under perfusion conditions and cyclic mechanical stimulation. The obtained results showed that mechanical stimulation of embryonic CMs is crucial to enhance cell proliferation and to create calcium transporting proteins, which are necessary in the process of cell contraction. It was investigated that mechanical conditions can be essential for the development of functional cardiac fragments (implants), which could replace damaged parts of the heart.
A muscular thin film (MTF) platform consisted of an anisotropic fragment of heart muscle cell tissue is the next interesting solution proposed as a functional cellular model (Grosberg et al. 2011). Such a 2D culture can compete with complex and advanced 3D models. Deformable elastic and flexible thin films made of PDMS, which are the component of MTF, were utilized to culture the neonatal rat ventricular myocytes. To enhance cell organization into an anisotropic form, thin PDMS layers were modified with ultraviolet (UV) light and fibronectin. The modification of culture surfaces can significantly increase cell viability and proliferation, and it can influence parallel cell orientation to each other. The CMs cultured on the designed microplatform were additionally electrical stimulated (square wave pulse, 5–20 V, 2 Hz, 10 ms duration). Thanks to the measurement of the curvature radius of MTF, the cell response to the external stimuli and cell contraction could be established.
Cocultures and multilayers are more advanced models of cardiac cell cultures, which mimic in vivo conditions better than monolayer cultures (Akins et al. 1999; Cheah et al. 2010; Horiguchi et al. 2009). CM cocultures with other types of heart cells allow enrichment of ECM with additional proteins and improvement of a 2D cell model (Gupta and Grande-Allen 2006; Liu et al. 2017). Cell coculture stimulates cell proliferation and increases the efficiency of cell signaling. Endothelial cells and cardiac fibroblasts are the cells, which are capable of producing complex ECM (Garzoni et al. 2009; Hussain et al. 2013; MacKenna et al. 2000; Saini et al. 2015). Additionally, because stem cells (SCs) play a very important role in regenerative medicine, these cells are also used in coculture with cardiac cells. They are utilized as a potential method to regenerate CMs (Garbern and Lee 2013; Ou et al. 2016). However, three-dimensional (3D) heart cultures are the most advanced cellular models used for heart research at the laboratory level. Spatial culture using heart tissue fragment (biopsy) can be performed in a microfluidic device (Cheah et al. 2010). The example of such a microsystem is shown in Fig. 8.5a. The microsystem consisted of a single flow chamber with a diameter of 7 mm. Right ventricular tissue from rat and right atrial tissue biopsies from patient were tested in the presented microdevice. The samples were placed in the microchamber, which was equipped with platinum electrodes for electrical stimulation. The presented microfluidic device was successfully used for real-time electrochemical monitoring of reactive oxygen species (ROS) release from a fragment of heart tissue. Additionally, cell damage was determined by measuring lactate dehydrogenase (LDH).
The scientists have also developed other methods for 3D cardiac cell cultures. 3D structures of CMs can be obtained by electrospinning, which uses the aligned biopolymer fibers as spatial scaffolds . Arrangement of CMs has been tested on nanofibers made of materials such as: poly(l-lactid-co-ε-caprolactone) [P(LLA-CL)] copolymer, poly(lactide-co-glycolide) (PLGA), poly(ε-caprolactone) (PCL), poly(hydroxybutyrate) (PHB), chitosan–polycaprolactone, polymethylglutarimide (PMGI) (Mannhardt et al. 2017; Rogozhnikov et al. 2016; Tomecka et al. 2017; Visone et al. 2016). Multilayers without the use of scaffolds can also be used to obtain 3D cell cultures. For this purpose, thermo-sensitive polymers (e.g., poly(N-isopropylacrylamide) can be applied. They are disintegrated at a cell safe temperature, at the last stage of cell culture (Kikuchi and Okano 2005; Shimizu et al. 2002, 2003). A laser microablation is also used to create 3D structure in biodegradable polymers [e.g., poly(glycerol sebacate)], characterized by high porosity and elasticity (Simmons et al. 2012). Hydrogels, which can be gelled under the influence of various external factors (ultraviolet irradiation, temperature, chemical factors), are also utilized for creation of CM spatial arrangement. For example, 3D cultures with controlled size and architecture can be performed using, e.g., fibrin-based or collagen-based hydrogel matrix generated by soft lithography technique (Ghiassedin et al. 2017; Visone et al. 2016; Zhang et al. 2016c). A micro-bioreactor with a network of microchannels, in which cardiac cells with chitosan hydrogel were successfully cultured, is shown in Fig. 8.5b. A high density of mice cardiac progenitor cells (CPC) were loaded into the microchambers and cultured for 10 days. Based on this method, spatial forms of cardiac tissue were created. Marsano et al. (2016) as one of the first examined how the simultaneous mechanical and biochemical stimulations affected the 3D culture of heart cells. A fibrin gel matrix was used to create 3D culture in a microsystem consisted of two PDMS layers with micropillars and a PDMS membrane. The micropillars in a top layer were used to create spatial models from both neonatal rat and human-induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM). A bottom layer with the micropillars and a PDMS membrane was used to induce homogeneous cyclic strains of 3D cell constructs. It was noted that the cyclic strain enhanced cardiac differentiation. High expression of cardiac markers such as cardiac troponin I and sarcomere α-actin was measured. Mechanical stimulation also influenced higher spontaneous cell beating. The proposed Heart-on-a-chip device was also used for evaluation of drug cytotoxicity.
The main challenge for the scientists is to develop an in vitro culture model, which has the ability to contract spontaneously. Additionally, heart cell models integrated with a microvessel network should be elaborated to mimic native heart tissue more. Such a network is responsible for proper distribution of oxygen and nutrients as well as removal of waste products (Gao et al. 2015). Bioprinting is a new technique used for tissue engineering . Compared with other tissue engineering approaches (e.g., the usage of scaffolds or hydrogels), bioprinting is an attractive method thanks to which fabrication of complex tissues also integrated with a vascular network is possible (Kolesky et al. 2016). A microsystem based on bioprinting can be a new approach in regenerative medicine, drug screening, and modeling of CVDs (Jia et al. 2016; Murphy and Antala 2014; Ozbolat 2015). There are a few bioprinting methods: bioprinting of cell-laden hydrogel 3D structures (Dhariwala et al. 2004), cell sheet lamination (Haraguchi et al. 2012), inkjet bioprinting (Boland et al. 2006), laser-assisted bioprinting (Yan et al. 2013), and extrusion-based bioprinting (Beyer et al. 2013). The materials used for bioprinting have specific properties. Functional inks based on piezo-resistive, high-conductance, and biocompatible soft materials (e.g., alginiane, gelatin methacryloyl) are most often used in this technology. Lind et al. (2016) presented an interesting microphysiological device, which was made using 3D bioprinting. To fabricate the microdevice, six inks with different properties were utilized. The sterilized and fibronectin-modified microsystem was used to culture neonatal rat ventricular myocytes (NRVMs) and human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs). The cells were exposed to the isoproterenol and verapamil as well as mechanical strain. The fabricated microsystem enabled the electrical measurement of cell functions and microscopic observation of the immunostained cells (i.e. sarcomere α-actin).
Zhang et al. (2016b) developed a microfluidic bioreactor with the network of blood vessels. Two PDMS layers created a main chamber with bioprinted scaffolds. The main chamber was additionally equipped with four micropillars, which were used to avoid scaffold movement during the flow of a culture medium. Alginate, gelatin methacryloyl (GelMA), photoinitiator Irgacure 2959 were the components of the bioink used for the bioprinting. Human umbilical vein endothelial cells (HUVECs) mixed with the bioink were bioprinted in the scaffolds . Next, CMs (neonatal rate CMs or hiPSC-CMs) were seeded on the created scaffolds. Finally, cell contraction and high expression of cardiac markers (e.g. sarcomere α-actin, connexin-43) were observed. The bioprinting procedure scheme is shown in Fig. 8.6a. It was noticed that HUVECs migrated toward the peripheries of the microfibers and formed a layer of a confluent endotheliumin. Coculture with cardiac cells created a complex and technologically advanced 3D heart model. The developed microsystem based on bioprinting scaffolds can also be successfully used for screening the efficacy and toxicity of cardiovascular drugs.
Multicellular spheroids are the next known 3D models of cell culture . Spheroids exhibit a number of characteristic in vivo features such as: spatial physical and biochemical intercellular interactions, morphology of the cytoskeleton similar to in vivo morphology, the presence of ECM as well as nutrient and oxygen gradients (Hamilton 1988). Although spheroids are most often considered as tumor model, they are also used to spatial cardiac cell culture (Lee et al. 2013; Oliveira et al. 2013; Ota et al. 2010). Garzoni et al. (2009) presented a 3D spheroid coculture of murine embryos with endothelial cells or bone marrow-derived mesenchymal stroma cells (Fig. 8.6b). New approach for cardiac spheroid formation was also proposed by Richards et al. (2016). They developed a microsystem for spheroid culture of hiPSC-CMs with silicon nanowires (Fig. 8.6c). Electrical stimulation was used to form the intercellular connections and the spontaneous contraction of CMs. The formed cardiac spheroids were used as a 3D model for in vitro investigation of heart muscle contraction.
8.2 Toxicity Assays
The pharmaceutical industry spends a lot of money on implementing new drugs in the market. In addition, it is a long-term process (about 10–15 years). Nonetheless, many of the implemented drugs are removed from the market due to their side effects, which are very often associated with cardiotoxicity. Some of the nonsteroidal anti-inflammatory drugs (NSAID) (e.g., rofecoxib, cisapride, tegaserod) belong to this group of compounds (Mordwinkin et al. 2013). Preclinical drug development can be limited by high cardiotoxicity of compounds developed to treat CVDs and other diseases. Detecting the potential side effects of drug action can reduce the cost of drug production and implementation. Therefore, in vitro cardiac cell models have two main purposes: (1) evaluating cardiotoxicity of new and approved drugs used for the treatment of various diseases, (2) evaluating therapies and drugs used to treat CVDs (Fermini and Fossa 2003). Toxicological and pharmacological tests performed on cardiac models play an important role in the development of personalized medicine (Zhang et al. 2016d). In vitro studies are conducted to investigate both the degree of cardiotoxicity and the preliminary assessment of the drug dose, which is safe for the heart. There are many classes of drugs, including non-cardiovascular ones, that cause significant side effects to heart tissue (e.g., anthracyclines and other cytostatic antitumor drugs, some antipsychotic drugs, and NSAIDs). Anthracyclines (e.g., doxorubicin, daunorubicin, epirubicin) as well as mitoxantrone, dasatinib, imatinib, and trastuzumab are anticancer drugs, which exhibit high cardiotoxicity (Kim et al. 2011; Zhang et al. 2017). Antipsychotics (e.g., clozapine, droperidol, thioridazine) can also disturb heart functions. They can cause heart inflammation, delay of cellular depolarization or tachycardia (Nozaki et al. 2014). Based on in vivo and in vitro studies, it is also known that analgesic drugs (e.g., naproxen, diclofenac, celecoxib, ketoprofen, ibuprofen) may also increase the risk of CVDs (Force and Kolaja 2011).
So far, cardiotoxicity is most often studied based on conventional, macroscale tests (Esch et al. 2014). To test the effect of chemical compounds and drugs, the viability of the cells is evaluated. Additionally, expression of cardiac markers is analyzed. Because CMs have a specific feature (a spontaneous contraction), the influence of compounds on cell beating is also investigated. Parameters such as the level of calcium ions and ROS generation are also monitored in CMs after drug exposure (Cheah et al. 2010; Saric et al. 2016). An important goal of cellular engineering is the development of in vivo-like heart culture models, in which cardiac cell functions as well as cardiotoxicity of various drugs will be possible to measure (Chan et al. 2013). There are several reports on Heart-on-a-chip systems, which have been reported to be promising tools for drug testing (Boudou et al. 2012; Kaneko et al. 2007; Sidorov et al. 2017) (see Table 8.1). Drugs used for CVD therapy, e.g., isoproterenol (nonselective β-adrenergic agonist used to treat bradycardia) and verapamil (calcium channel blocker with antiarrhythmic properties) have often been investigated in Heart-on-a-chip systems (Agarwal et al. 2013; Marsano et al. 2016; Tomecka et al. 2018). Agarwal et al. (2013) presented a microfluidic system based on muscular thin films (MTFs) as a new approach for cardiotoxicity measurements (Fig. 8.7a). The microsystem was integrated with a transparent polycarbonate layer for recording MTF deformation, aluminum heating elements, and platinum electrodes for electrical stimulation. Neonatal rat ventricular myocytes were cultured on a thin flexible PDMS film, which was microprinted with fibronectin. Cardiac contraction was investigated after isoproterenol exposure (1 nM–100 μM). It was observed that cell contraction is dependent on drug dosage and concentration. The proposed microplatform is a promising tool possible to use as a commercial platform for cardiotoxicity analysis of various drugs. Cytotoxicity assays performed on spatial cultures could have a high impact on development of heart research. Such approach has been presented by Marsano et al. (2016). They investigated cardiotoxicity of isoprotenerol on human cardiac microtissues (3D culture) in a Heart-on-a-chip system. Mechanical and electrical stimulations were used to mimic in vivo-like conditions during the experiments. An increase in the cardiac cell contraction rate was observed after cell exposure to isoproterenol (10−12–10−6 M) and electrical stimulation (square pulse, a duration of 4 ms, a frequency of 1 Hz). A microscopic observation is most often used to measure cell viability in the microsystems . Therefore, electrical impedance spectroscopy was proposed as the noninvasive, real-time, and quantitative method to study cardiotoxicity in a microdevice (Zhang et al. 2016a). The device consisted of polystyrene chambers and nonconductive substrate with gold electrodes (Fig. 8.7b). Verapamil (in the range of 0–2 µM) as a drug used for CVD treatment and doxorubicin (in the range of 0–15 µM) as an anticancer drug were selected for the experiments. The viability and contractions of CMs isolated from neonatal rats after exposure to the tested compounds were studied. The results showed that impedance spectroscopy can be successfully used for real-time determination of drug cardiotoxicity in the microsystems.
As it was mentioned above, there are drugs, which cause significant side effects to heart tissue. Based on this, the Heart-on-a-chip systems applied for cardiotoxicity analysis of antipsychotic and anticancer drugs are more and more developed (Grosberg et al. 2011; Hansen et al. 2010; Kaneko et al. 2007). For example, Grosberg et al. (2011) used a static culture of neonatal rat ventricular myocytes to study the cardiotoxicity of epinephrine—a catecholamine neurotransmitter with properties that stimulate myocardial contractility. Kaneko et al. (2007) presented a microsystem for investigation of the cardiotoxicity of haloperidol (antipsychotic drug) on a single cardiac cell culture . It should be noted that a new microplatform based on engineered heart tissue (EHT) was also developed to test drug cardiotoxicity (Hansen et al. 2010). The microplatform was used to study compounds such as: chromanol 293B (potassium channel blocker), quinidine and erythromycin (both used to treat arrhythmia), and doxorubicin (an anticancer drug). To create EHT-like culture model, neonatal rat heart cells were mixed with fibrinogen and Matrigel with thrombin, and they were cultured in the microdevice. Cell contraction was observed 8–10 days after cell seeding. Such cultures were exposed to the above listed drugs. Cell response (e.g., contraction) to the drugs was monitored using a video-optical technique. The authors confirmed that chromanol, quinidine, and erythromycin (depending on the concentration) increased the relaxation time, and doxorubicin decreased the contraction force. The developed microplatform can be useful for clinical pharmacology studies.
The Heart-on-a-chip systems can be used not only for analysis of drug cardiotoxicity, but also for mimicking CVDs. Heart diseases such as hypoxia, arrhythmia, ischemia, or myocardial infarction have been analyzed in the Heart-on-a-chip systems (Chen et al. 2017; Grosberg et al. 2011; Klauke et al. 2003; Ren et al. 2013; Sidorov et al. 2017). Ren et al. (2013) presented a PDMS microsystem for the dynamic study of hypoxia-induced myocardial injury in a controlled microenvironment. The microsystem consisted of three microchannels: central one used for culture and investigation of rat myocardium cells (H9C2) and two side microchannels for introduction of a culture medium and tested solutions (Fig. 8.8a). Hypoxia-induced myocardial injury was simulated using FCCP (carbonyl cyanide-p-trifluoromethoxyphenylhydrazone) (50 µM for 2 h). To study the hypoxic injury dynamics of H9C2 cells, the mitochondrial membrane potential and caspase-3 activity of the cells were analyzed. The usage of FCCP caused disintegration of the cytoskeleton and loss of mitochondrial membrane potential of the myocardium cells. It was noticed that the developed microsystem can be successfully used to mimic physiological and pathological conditions in heart tissue, and it has a high potential to study heart regeneration . The second microsystem, which can have also high impact on heart-based research, is a microsystem mimicking the function of a whole cardiovascular system (Chen et al. 2017). The designed microsystem was integrated with a cardiac-like, on-chip pumping system. It consisted of four pumps and valves, which imitated heart atriums, ventricles, and valves. It generated a one-way, circular flow of a culture medium (Fig. 8.8b). HUVECs were cultured in the microsystem, and their response to mechanical forces generated inside the microchannels was investigated. The fabricated microsystem can also be used as a microtool for modeling vascular diseases such as: bradycardia (a lower heart beat rate compared to healthy tissue) and hypotension (lower peak pressure compared to healthy tissue). The methods based on the pressure changing inside the microchannels were used to mimic these diseases in the microsystem.
8.3 Electrical Field
CMs in the native heart tissue form a complex network of neighboring and contacting cells. The pacemaker cells, which are 1% of cardiac cells, regulate the transmission of electrical pulses to the other cells of the heart. These cells are responsible for the generation of electrical pulses or action potentials that maintain electrical connectivity across the tissue (Dorn et al. 2015). Because electrical pulses are presented in the native heart tissue, such conditions should also be mimicked in vitro. For this purpose, an external electrical field is utilized. Electrical stimulation influences the rate, duration, and number of CM action potentials. It induces CM contraction and increases the number of spontaneously beating cells. Moreover, the electrical field affects the transport of calcium ions between the cells. Electrical stimulation of CMs was studied in both macro- and microscale (Barash et al. 2010; Maidhof et al. 2012; Zhang et al. 2013a; Vacek et al. 2011). Studies have shown that electrical stimulation influences CMs at the molecular level. It has influence on the formation of gaps and intercellular connections and the increase of the expression of cardiac markers. An electrical field was used to stimulate cell migration and orientation (parallel to each other) (Mannhardt et al. 2017; Shin et al. 2016).
Parameters such as electrical field value, signal type, frequency, pulse duration, and exposure time have to be optimized during electrical stimulation (Tandon et al. 2010, 2011). Biphasic square pulses, in the range of 1–20 V cm−1, at a frequency of 1–10 Hz and duration impulse between 1 and 4 ms are parameters most often used for CM stimulation. There are two main methods utilized for generation of electrical field in the Heart-on-a-chip systems. The first is based on the placement an anode and a cathode in a culture medium. Thanks to this, a uniform electrical field is obtained (Ribas et al. 2016; Serena et al. 2009). Although this method can be easily integrated with the microsystems , it has a few disadvantages. For instance, a single cell is not well characterized during the stimulation and it is possible to generate a pH gradient in the culture microenvironment. The integration of the microsystems with planar electrodes and multi-unit electrode arrays (MEAs) is the next method used to generate electrical field (Ma et al. 2012; Natarajan et al. 2011; Simmons et al. 2012; Yu et al. 2012). The example of MEA used for CM stimulation is shown in Fig. 8.9a (Natarajan et al. 2011). MEA allows electrical field to be precisely regulated. Thanks to the utilization of such microarrays, it is possible to stimulate a whole cell population as well as a single cell. MEAs can be used to generate a high value electrical field (0.1–10 V) on a small working surface (instead of using high absolute voltages). An important benefit of MEAs is that they allow both stimulation of the CMs and real-time recording of CMs exposure to various external factors (Werdich et al. 2004).
Electrodes made of various types of materials are utilized for cell stimulation in Heart-on-a-chip systems: e.g., stainless steel, carbon platinum, gold, indium tin oxide (ITO) (Table 8.2) (Jastrzebska et al. 2016; Serena et al. 2009; Tandon et al. 2010; Wei et al. 2011). Gold or platinum wires are most often integrated with the microsystems (Chen et al. 2009; Klauke et al. 2003). Stretchable and flexible electrodes made of a thin layer of gold are also used (Rogers et al. 2010). Spiral electrodes made of carbon nanotubes (Khang et al. 2008) and silver nanoparticles (Ahn et al. 2009) have also been reported as new types of electrodes integrated with the microsystems .
Different types of cell cultures (single-cell, monolayer , and 3D cultures) were stimulated with an electric field in the microsystems. The type of culture model has an influence on the phenotype and functions of CMs. Several reports based on 2D cultures have been presented in the literature (Agarwal et al. 2013; Au et al. 2009; Cheng et al. 2010; Natarajan et al. 2011). Single adult rabbit ventricular myocytes isolated from the left ventricle were cultured and stimulated in a microsystem consisting of 15 microwells (Cheng et al. 2010). Each microwell was integrated with a set of five microelectrodes (two Pt stimulating electrodes, a Pt working electrode, a Pt counter electrode, and an Ag/AgCl reference electrode). Au et al. (2009) developed a microfluidic platform for CM culture and their electrical stimulation. The microsystem made of polystyrene (PS) was used for investigation of neonatal rat CMs. The microsystem consisted of microgrooves and microridges with a precisely defined depth (400 nm), width (0.5 or 3 µm wide grooves and 0.5 or 1 µm wide ridges), and periodicity (1 and 4 µm). Smooth polystyrene surfaces were used as control samples. The designed microsystem was integrated with two gold electrodes. The electrodes were oriented in such a way that they were placed either parallelly or perpendicularly to the microgrooves. Such an electrode arrangement enabled the investigation of the dependence between topographical factor and electrical signal. The cells were treated with symmetric biphasic pulses (electrical field of 1.15 V cm−1, a frequency of 1 Hz, a duration of 1 ms) for 7 days. Sarcomere α-actin staining showed that such stimulation caused elongation and alignment of the cells along the microgrooves. It was also observed that cellular orientation was greatly determined by the topographical signals. Electrical field stimulation further enhanced cardiomyocyte elongation, when microgrooves were oriented parallelly to electrical field. The obtained results showed that the presented microsystem can be a useful tool for drug development (tests for verapamil were also performed). Zhang et al. (2013b) presented a microsystem used for electrical stimulation of adult cardiac myocytes (Fig. 8.9b). The developed microsystem was used to study the intercellular electromechanical transduction by measuring the contractile performance of the stimulated and non-stimulated cells. The microsystem was integrated with micropatterned gold electrodes (a width of 200 µm). CMs isolated from the left heart ventricle were exposed to an electric voltage pulse with a frequency of 1 Hz and a duration of 8 ms. The measurements were performed on the cells, which were placed between the two neighboring electrodes. Cell contraction was determined by measuring the change of cell length. Researches demonstrated that the presented microsystem is useful in studying the efficiency of gap junctions in adult cardiac myocytes.
Electrical field can also induce synchronous contractions in spatial cell cultures (Radisic et al. 2004). 3D cultures performed in the microsystems and application of electrical field are recognized as a useful method in regenerative medicine. The Heart-on-a-chip systems based on a 3D culture are utilized for investigation of electrical stimulation more and more (Barash et al. 2010; Boudou et al. 2012; Hirt et al. 2014; Lind et al. 2016; Schroer et al. 2017; Xiao et al. 2014). Boudou et al. (2012) developed an interesting microplatform for measurement and manipulation of 3D cardiac cell models using carbon electrodes. Cardiomyocytes isolated from neonatal rat, cultured as cardiac microtissues (CMTs) in collagen and fibrin 3D matrices, were used in the experiments. Two parallel carbon electrodes placed on both sides of the microplatform were used for cell stimulation. The CMTs were stimulated using biphasic pulses (6 V cm−1, 0.2 Hz, 1 ms). The effect of electrical stimulation on cell alignment and force generation within CMTs was investigated in this study. It was noticed that electrical stimulation improves both the structure and the function of CMTs. It is also important that the developed microplatform can become a potential microtool for monitoring the action of drugs on electrically stimulated 3D cardiac cell models.
The influence of electrical field, and dependence of electrodes arrangement, was investigated in 3D micro-tissue biowires (Xiao et al. 2014). The biowires integrated with carbon rod electrodes were utilized for investigation of primary neonatal rat CMs and human embryonic stem cell-derived CMs (hESC-CMs). Different electrical stimulation (biphasic, rectangular, 1 ms duration, 1.2 Hz, 3.5–4 V cm−1, for 4 days) conditions were applied dependent on a cell type. Rat cardiac biowires were stimulated using both the parallel stimulation chambers (two carbon rods placed 2 cm apart and perpendicular to the biowires) and the perpendicular stimulation chambers (two carbon rods placed 1 cm apart and parallel with the biowires) (Fig. 8.9c). Cell function was analyzed based on the immunostaining of cardiac Troponin T and connexin-43 as well as the mechanical properties of the cells. The obtained results showed that the proposed microdevice can be successfully utilized for investigation of the influence of electrical stimulation on cell functions.
Understanding the role of electrical stimulation in cell metabolic pathways is important in the field of heart tissue engineering . Although many reports based on electrical stimulation of CMs in the microsystems have been presented in the literature, there are still research areas, which have to be deeply studied: e.g., imitation of fully functioning heart tissue, mimicking of CVDs, and regeneration of the CMs based on electric fields (Schroer et al. 2017).
8.4 Monitoring CM Functions
Developing a microsystem especially for culture and investigation of heart cells is associated with selection of methods for analysis of cell functions (Fig. 8.10). Based on the features, which characterize heart cells (especially CMs) parameters such as the expression of cardiac markers, cell contraction/beating, and the level of calcium ions, are often determined in the Heart-on-a-chip systems. Besides the above-mentioned assays, cell proliferation, cell viability as well as cell morphology are studied (Mordwinkin et al. 2013). To monitor the CM functions listed above, various instrumental (electrochemical and optical) techniques are utilized.
The examples of Heart-on-a-chip systems described in previous sections showed that they are appropriate tools to perform both heart cell cultures and cardiotoxicity studies. Analysis of growth and proliferation of the CMs are mainly studied in the microsystems used for cell culture , toxicity assays, and electrical stimulation. The proliferation and viability of the cells can be determined by differential staining with fluorescent dyes (e.g., Calcein AM and Propidium iodide and Ethidium homodimer-1) and microscopic observations (e.g., confocal microscopy, optical and fluorescence microscopy) (Ghiaseddin et al. 2017; Marsano et al. 2016; Ren et al. 2013). Besides that, cell proliferation and CM maturation after an external stimulus can be determined by analyzing the expression of cardiac markers. Expression of typical cardiac markers and expression of structural proteins such as sarcomere α-actin, cardiac troponin I, cardiac troponin T, connexin-43, myosin heavy chain 6 (MYH6), and myosin light chain 2a are the most often monitored in heart cellular models (Belaguli et al. 2000; Serena et al. 2009; Tandon et al. 2010). These markers are determined by immunofluorescent staining with a fluorochrome (most often Alexa Fluor family). Grosberg et al. (2011) evaluated cell structure by immunofluorescent staining with Alexa Fluor 488-conjugated Phalloidin (F-actin, green dye) and Alexa Fluor 594-conjugated clone EA-53 (sarcomeric α-actin, red dye). Agarwal et al. (2013) proposed similar immunostaining for analyzing the formation of the anisotropic monolayer of CMs. They used immunostaining with Alexa Fluor 633-conjugated Phalloidin (F-actin, red dye) and Alexa Fluor 546-conjugated clone EA-53 (sarcomeric α-actin red dye). To determine the expression of cardiac markers, similar parameters were used by other research groups.
Cyclic voltammetry can also be utilized to determine viability and proliferation of cardiac cells cultured in the microsystems (Cheah et al. 2010). Such a technique allows the amount of reactive oxygen species to be measured in real-time. The calcium ion level in the cells was used for monitoring cardiac cell viability and proliferation. For this purpose, fluorescent dyes can be used (fluo-3 or fluo-4) (Klauke et al. 2003). The amount of calcium ions can be evaluated for normal (healthy) as well as hypoxia-induced cardiac hypertrophy (disease) conditions. Additionally, the mitochondrial membrane potential (using JC-1 indicator) and caspase-3 activity of the cells can be analyzed after an external stimulus. These parameters are used to evaluate culture states (He et al. 2014; Ren et al. 2013). Transmission electron microscopy is also applied to analyze micro-tissue cell models. Such a technique is used, e.g., to determine the morphology and pore structure of the prepared hydrogels placed in the microsystems (Ghiaseddin et al. 2017). Cell morphology and arrangement are monitored using microscopy techniques. Typical cardiomyocyte structural properties such as glycogen granules, mitochondria, myofibrils, sarcoplasmic reticulum striated sarcomeres, A-bands, I-bands, and Z-lines can be successfully determined using microscopic techniques (Mordwinkin et al. 2013).
In the recent years, impedance spectroscopy (IS) is intensively developing technology for analysis of cell proliferation in the microfluidic systems (Zhang et al. 2016a). IS is a noninvasive electrochemical method, which can be used for real-time monitoring of cell proliferation, viability as well as contraction (Dean et al. 2007; Min et al. 2003; Qiu et al. 2008, 2009). Contraction is the most specific feature of CMs. This parameter is determined using techniques such as: microscopic observation, impedance spectroscopy and MEA techniques, micropillar and microsensor deflections (Marsano et al. 2016; Natarajan et al. 2011; Tanaka et al. 2007). Many of analytical techniques, applied to monitor CM functions in the microsystems, are based on qualitative analysis. Such methods are especially used for spatial cell cultures. Therefore, it is important to elaborate quantitative, repeatable methods, which can be validated and implemented not only for 2D but also for 3D cell cultures in the Heart-on-a-chip systems.
8.5 Summary and Perspectives
The Heart-on-a-chip systems are used to create in vivo-like culture models. They provide new possibilities in many biological and preclinical studies. Properly designed microstructures of the microsystems provide an opportunity to perform rapid drug screening and analysis of the effects of external stimulation. Thanks to this, new mechanisms and cardiac cell functions can be discovered and can consequently be useful in regenerative medicine. Many examples of heart culture models have been presented in the literature. There are Heart-on-a-chip systems for single, monolayer , and spatial cell cultures, in which the cardiotoxicity of different drug groups as well as the influence of external stimulation on cardiac cell cultures were studied.
Because heart cells have specific features (dynamic conditions, stretching and electrical impulses), the Heart-on-a-chip systems have to be equipped with the elements, which ensure such properties. This brings many challenges during the development of the microsystems for cardiac cell culture . The most important problem is the origin of the beating cardiomyocytes . To obtain such cells, some embryo and neonatal specimens are utilized. Therefore, cells coming from animals are the most often used. Human cardiac cells from adults are also investigated; however, they are often characterized by the lack of the beating. Therefore, beating stem cell-derived cardiomyocytes (SC-CMs) have been increasingly cultured. Although a number of the microsystems for heart cell cultures (e.g., for single, 2D, and 3D cell cultures) is developed, they present not fully functioning heart model. The research, in which these cardiac models are used, still is in the early stage. However, the combination of different solutions, the microsystems and the culture methods, proposed by many research groups and described in this chapter, could improve investigation based on the Heart-on-a-chip systems and could implement such microsystems in a personalized medicine in the future. Some aspects should still be investigated and improved in the microsystems proposed so far. The combination of a whole vascular system with a 3D beating heart cellular model and study physiological and pathological conditions in such a fully mimicked cardiovascular system is a perspective for Heart-on-a-chip system developing. The usage of a spatial and vascular model for a detailed investigation of CM regeneration is also an important step which should be developed. So far, microscopic observations are mainly used to evaluate the state of 3D culture in the microsystems . Therefore, the elaboration of quantitative microfluidic methods for examination of biochemical processes in cardiovascular system is strongly important. This approach for Heart-on-a-chip study can be based on the usage of a perfusion microsystem enriched with additional structural elements for cellular spatial culture and components for automated analytical measurements (e.g., electrodes, integration with commercially available equipment). Moreover, the usage of a digitally controlled module can allow automated dosage of all fluids, and finally it can increase usefulness of such a microsystem in a personalized medicine.
References
Agarwal A, Goss JA, Cho A, McCain ML, Parker KK (2013) Microfluidic heart on a chip for higher throughput pharmacological studies. Lab Chip 13:3599–3608
Ahn BY, Duoss EB, Motala JM, Guo X, Park S-I, Xiong Y, Yoon J, Nuzzo RG, Rogers JA, Lewis JA (2009) Omnidirectional printing of flexible, stretchable, and spanning silver microelectrodes. Science 323:1590–1593
Akins RE, Boyce RA, Madonna ML, Schroedl NA, Gonda SR, McLaughlin TA, Hartzell CR (1999) Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. Tissue Eng 5:103–118
Annabi N, Selimovic S, Acevedo Cox JP, Ribas J, Afshar Bakooshli M, Heintze D, Weiss AS, Cropek D, Khademhosseini A (2013) Hydrogel-coated microfluidic channels for cardiomyocyte culture. Lab Chip 13:3569–3577
Au HTH, Cui B, Chu ZE, Veres T, Radisic M (2009) Cell culture chips for simultaneous application of topographical and electrical cues enhance phenotype of cardiomyocytes. Lab Chip 9:564–575
Barash Y, Dvir T, Tandeitnik P, Ruvinov E, Guterman H, Cohen S (2010) Electric field stimulation integrated into perfusion bioreactor for cardiac tissue engineering. Tissue Eng Part C Methods 16:1417–1426
Belaguli NS, Sepulveda JL, Nigam V, Charron F, Nemer M, Schwartz RJ (2000) Cardiac tissue enriched factors serum response factor and gata-4 are mutual coregulators. Mol Cell Biol 20:7550–7558
Beyer ST, Bsoul A, Ahmadi A, Walus K (2013) 3D alginate constructs for tissue engineering printed using a coaxial flow focusing microfluidic device. IEEE 1206–1209. doi:10.1109/Transducers.2013.6626990
Bhaarathy V, Venugopal J, Gandhimathi C, Ponpandian N, Mangalaraj D, Ramakrishna S (2014) Biologically improved nanofibrous scaffolds for cardiac tissue engineering. Mater Sci Eng C Mater Biol Appl 44:268–277
Boland T, Xu T, Damon B, Cui X (2006) Application of inkjet printing to tissue engineering. Biotechnol J 1:910–917
Boudou T, Legant WR, Mu A, Borochin MA, Thavandiran N, Radisic M, Zandstra PW, Epstein JA, Margulies KB, Chen CS (2012) A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng Part A 18:910–919
Chan CY, Huang PH, Guo F, Ding X, Kapur V, Mai JD, Yuen PK, Huang TJ (2013) Accelerating drug discovery via organs-on-chips. Lab Chip 13:4697–4710
Cheah LT, Dou YH, Seymour AM, Dyer CE, Haswell SJ, Wadhawan JD, Greenman J (2010) Microfluidic perfusion system for maintaining viable heart tissue with real-time electrochemical monitoring of reactive oxygen species. Lab Chip 10:2720–2726
Chen MQ, Xie X, Wilson KD, Sun N, Wu JC, Giovangrandi L, Kovacs GT (2009) Current-controlled electrical point-source stimulation of embryonic stem cells. Cell Mol Bioeng 2:625–635
Chen Y, Chan HN, Michael SA, Shen Y, Chen Y, Tian Q, Huang L, Wu H (2017) A microfluidic circulatory system integrated with capillary-assisted pressure sensors. Lab Chip 17:653–662
Cheng W, Klauke N, Sedgwick H, Smith GL, Cooper JM (2006) Metabolic monitoring of the electrically stimulated single heart cell within a microfluidic platform. Lab Chip 6:1424–1431
Cheng W, Klauke N, Smith G, Cooper JM (2010) Microfluidic cell arrays for metabolic monitoring of stimulated cardiomyocytes. Electrophoresis 31:1405–1413
Conant G, Lai BFL, Lu RXZ, Korolj A, Wang EY, Radisic M (2017) High-content assessment of cardiac function using heart-on-a-chip devices as drug screening model. Stem Cell Rev 13:335–346
Dahl KN, Kalinowski A, Pekkan K (2010) Mechanobiology and the microcirculation: cellular, nuclear and fluid mechanics. Microcirculation 17:179–191
Dean DA, Ramanathan T, Machado D, Sundararajan R (2007) Electrical impedance spectroscopy study of biological tissues. J Electrostat 66:165–177
Dhariwala B, Hunt E, Boland T (2004) Rapid prototyping of tissue-engineering constructs, using photopolymerizable hydrogels and stereolithography. Tissue Eng 10:1316–1322
Dorn T, Goedel A, Lam JT, Haas J, Tian Q, Herrmann F, Bundschu K, Dobreva G, Schiemann M, Dirschinger R, Guo Y, Kühl SJ, Sinnecker D, Lipp P, Laugwitz KL, Kühl M, Moretti A (2015) Direct nkx2-5 transcriptional repression of isl1 controls cardiomyocyte subtype identity. Stem Cells 33:1113–1129
Esch MB, Smith AS, Prot JM, Oleaga C, Hickman JJ, Shuler ML (2014) How multi-organ microdevices can help foster drug development. Adv Drug Deliv Rev 69–70:158–169
Fermini B, Fossa AA (2003) The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov 2:439–447
Force T, Kolaja KL (2011) Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes. Nat Rev Drug Discov 10:111–126
Gao Q, He Y, Fu JZ, Liu A, Ma L (2015) Coaxial nozzle-assisted 3D bioprinting with built-in microchannels for nutrients delivery. Biomaterials 61:203–215
Garbern JC, Lee RT (2013) Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell 12:689–698
Garzoni LR, Rossi MID, de Barros APDN, Guarani V, Keramidas M, Balottin LBL, Adesse D, Takiya CM, Manso PP, Otazú IB, de Nazareth Meirellesa M, Borojevic R (2009) Dissecting coronary angiogenesis: 3D co-culture of cardiomyocytes with endothelial or mesenchymal cells. Exp Cell Res 315:3406–3418
Ges IA, Ivanov BL, Schaffer DK, Lima EA, Werdich AA, Baudenbacher FJ (2005) Thin-film IrOx pH microelectrode for microfluidic-based microsystems. Biosens Bioelectron 21:248–256
Ges IA, Dzhura IA, Baudenbacher FJ (2008) On-chip acidification rate measurements from single cardiac cells confined in sub-nanoliter volumes. Biomed Microdevices 10:347–354
Ghiaseddin A, Pouri H, Soleimani M, Vasheghani-Farahani E, Ahmadi Tafti H, Hashemi-Najafabadi S (2017) Cell laden hydrogel construct on-a-chip for mimicry of cardiac tissue in-vitro study. Biochem Biophys Res Commun 484:225–230
Grosberg A, Alford PW, McCain ML, Parker KK (2011) Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. Lab Chip 11:4165–4173
Gupta V, Grande-Allen KJ (2006) Effects of static and cyclic loading in regulating extracellular matrix synthesis by cardiovascular cells. Cardiovasc Res 72:375–383
Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, O’Farrell FM, Buchan AM, Lauritzen M, Attwell D (2014) Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508:55–60
Hamilton G (1988) Multicellular spheroids as an in vitro tumor model. Cancer Lett 131:29–34
Hansen A, Eder A, Bönstrup M, Flato M, Mewe M, Schaaf S, Aksehirlioglu B, Schwoerer AP, Uebeler J, Eschenhagen T (2010) Development of a drug screening platform based on engineered heart tissue. Circ Res 107:35–44
Haraguchi Y, Shimizu T, Yamato M, Okano T (2012) Scaffold-free tissue engineering using cell sheet technology. RSC Adv 2:2184–2190
He J, Ma C, Liu W, Wang J (2014) On-chip monitoring of skeletal myoblast transplantation for the treatment of hypoxia-induced myocardial injury. Analyst 139:4482–4490
Hirt MN, Boeddinghaus J, Mitchell A, Schaaf S, Börnchen C, Müller C, Schulz H, Hubner N, Stenzig J, Stoehr A, Neuber C, Eder A, Luther PK, Hansen A, Eschenhagen T (2014) Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J Mol Cell Cardiol 74:151–161
Horiguchi H, Imagawa K, Hoshino T, Akiyama Y, Morishima K (2009) Fabrication and evaluation of reconstructed cardiac tissue and its application to bio-actuated microdevices. IEEE 8:349–355. doi:10.1109/TNB.2009.2035282
Hussain A, Collins G, Yip D, Cho CH (2013) Functional 3-D cardiac co-culture model using bioactive chitosan nanofiber scaffolds. Biotechnol Bioeng 110:637–647
Jastrzebska E, Tomecka E, Jesion I (2016) Heart-on-a-chip based on stem cell biology. Biosens Bioelectron 75:67–81
Jia W, Gungor-Ozkerim PS, Zhang YS, Yue K, Zhu K, Liu W, Pi Q, Byambaa B, Dokmeci MR, Shin SR, Khademhosseini A (2016) Direct 3D bioprinting of perfusable vascular constructs using a blend bioink. Biomaterials 106:58–68
Kaneko T, Kojima K, Yasuda K (2007) An on-chip cardiomyocyte cell network assay for stable drug screening regarding community effect of cell network size. Analyst 132:892–898
Khang DY, Xiao J, Kocabas C, MacLaren S, Banks T, Jiang H, Huang YY, Rogers JA (2008) Molecular scale buckling mechanics in individual aligned single-wall carbon nanotubes on elastomeric substrates. Nano Lett 8:124–130
Kikuchi A, Okano T (2005) Nanostructured designs of biomedical materials: applications of cell sheet engineering to functional regenerative tissues and organs. J Control Release 101:69–84
Kim SB, Bae H, Cha JM, Moon SJ, Dokmeci MR, Cropek DM, Khademhosseini A (2011) A cell-based biosensor for real-time detection of cardiotoxicity using lensfree imaging. Lab Chip 11:1801–1807
Klauke N, Smith GL, Cooper J (2003) Stimulation of single isolated adult ventricular myocytes within a low volume using a planar microelectrode array. Biophys J 85:1766–1774
Kobuszewska A, Tomecka E, Zukowski K, Jastrzebska E, Chudy M, Dybko A, Renaud P, Brzozka Z (2017) Heart-on-a-Chip: an investigation of the influence of static and perfusion conditions on cardiac (H9C2) cell proliferation, morphology, and alignment. SLAS Technol 22:536–546
Kolesky DB, Homan KA, Skylar-Scott MA, Lewis JA (2016) Three-dimensional bioprinting of thick vascularized tissues. Proc Natl Acad Sci U S A 113:3179–3184
Kujala VJ, Pasqualini FS, Goss JA, Nawroth JC, Parker KK (2016) Laminar ventricular myocardium on a microelectrode array-based chip. J Mater Chem B 4:3534–3543
Lee SA, da No Y, Kang E, Ju J, Kim DS, Lee SH (2013) Spheroid-based three-dimensional liver-on-a-chip to investigate hepatocyte-hepatic stellate cell interactions and flow effects. Lab Chip 13:3529–3537
LeGrice IJ, Smaill BH, Chai LZ, Edgar SG, Gavin JB, Hunter PJ (1995) Laminar structure of the heart: ventricular myocyte arrangement and connective tissue architecture in the dog. Am J Physiol 269:H571–H582
Lind JU, Busbee TA, Valentine AD, Pasqualini FS, Yuan H, Yadid M, Park SJ, Kotikian A, Nesmith AP, Campbell PH, Vlassak JJ, Lewis JA, Parker KK (2016) Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing. Nat Mater 16:303–308
Liu Y, Xia T, Wei J, Liu Q, Li X (2017) Micropatterned co-culture of cardiac myocytes on fibrous scaffolds for predictive screening of drug cardiotoxicities. Nanoscale. 9:4950–4962
Ma Z, Liu Q, Liu H, Yang H, Yun JX, Eisenberg C, Borg TK, Xu M, Gao BZ (2012) Laser-patterned stem-cell bridges in a cardiac muscle model for on-chip electrical conductivity analyses. Lab Chip 12:566–573
MacKenna D, Summerour SR, Villarreal FJ (2000) Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc Res 46:257–263
Maidhof R, Tandon N, Lee EJ, Luo J, Duan Y, Yeager K, Konofagou E, Vunjak-Novakovic G (2012) Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. J Tissue Eng Regen Med 6:e12–e23
Maksimov VF, Korostyshevskaya IM, Kurganov SA, Markel AL, Rudenko NS, Yacobson GS (2015) Changes in myoendocrine cells in rat right atrium at hypertension and during pharmacological lowering of blood pressure. Cell and Tissue Biology 9:30–39
Mannhardt I, Saleem U, Benzin A, Schulze T, Klampe B, Eschenhagen T, Hansen A (2017) Automated contraction analysis of human engineered heart tissue for cardiac drug safety screening. J Vis Exp. doi:10.3791/55461
Marsano A, Conficconi C, Lemme M, Occhetta P, Gaudiello E, Votta E, Cerino G, Redaelli A, Rasponi M (2016) Beating heart on a chip: a novel microfluidic platform to generate functional 3D cardiac microtissues. Lab Chip 16:599–610
Min M, Ollmar S, Gersing E (2003) Electrical impedance and cardiac monitoring - technology, potential and applications. Int J Bioelectromagn 5:53–56
Mordwinkin NM, Burridge PW, Wu JC (2013) A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards. J Cardiovasc Transl Res 6:22–30
Murphy SV, Atala A (2014) 3D bioprinting of tissues and organs. Nat Biotechnol 32:773–785
Natarajan A, Stancescu M, Dhir V, Armstrong C, Sommerhage F, Hickman JJ, Molnar P (2011) Patterned cardiomyocytes on microelectrode arrays as a functional, high information content drug screening platform. Biomaterials 32:4267–4274
Nguyen MD, Tinney JP, Ye F, Elnakib AA, Yuan F, El-Baz A, Sethu P, Keller BB, Giridharan GA (2015) Effects of physiologic mechanical stimulation on embryonic chick cardiomyocytes using a microfluidic cardiac cell culture model. Anal Chem 87:2107–2113
Nozaki Y, Honda Y, Tsujimoto S, Watanabe H, Kunimatsu T, Funabashi H (2014) Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation. Toxicol Appl Pharmacol 278:72–77
Oliveira MB, Neto AI, Correia CR, Rial-Hermida MI, Alvarez-Lorenzo C, Mano JF (2013) Superhydrophobic chips for cell spheroids high-throughput generation and drug screening. ACS Appl Mater Interfaces 6:9488–9495
Ota H, Yamamoto R, Deguchi K, Tanaka Y, Kazoe Y, Sato Y, Miki N (2010) Three-dimensional spheroid-forming lab-on-a-chip using micro-rotational flow. Sensors Actuat B 147:359–365
Ou D, Wang Q, Huang Y, Zeng D, Wei T, Ding L, Li X, Zheng Q, Jin Y (2016) Co-culture with neonatal cardiomyocytes enhances the proliferation of iPSC-derived cardiomyocytes via FAK/JNK signaling. BMC Dev Biol 16:11–22
Ozbolat IT (2015) Bioprinting scale-up tissue and organ constructs for transplantation. Trends Biotechnol 33:395–400
Qiu Y, Liao R, Zhang X (2008) Real-time monitoring primary cardiomyocyte adhesion based on electrochemical impedance spectroscopy and electrical cell-substrate impedance sensing. Anal Chem 80:990–996
Qiu Y, Liao R, Zhang X (2009) Intervention of cardiomyocyte death based on real-time monitoring of cell adhesion through impedance sensing. Biosens Bioelectron 25:147–153
Radisic M, Park H, Shing H, Consi T, Schoen FJ, Langer R, Freed LE, Vunjak-Novakovic G (2004) Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A 101:18129–18134
Ralphe JC, de Lange WJ (2013) 3D engineered cardiac tissue models of human heart disease: learning more from our mice. Trends Cardiovasc Med 23:27–32
Ren L, Liu W, Wang Y, Wang JC, Tu Q, Xu J, Liu R, Shen SF, Wang J (2013) Investigation of hypoxia-induced myocardial injury dynamics in a tissue interface mimicking microfluidic device. Anal Chem 85:235–244
Ribas J, Sadeghi H, Manbachi A, Leijten J, Brinegar K, Zhang YS, Ferreira L, Khademhosseini A (2016) Cardiovascular organ-on-a-Chip platforms for drug discovery and development. Appl In Vitro Toxicol 2:82–96
Richards DJ, Tan Y, Coyle R, Li Y, Xu R, Yeung N, Parker A, Menick DR, Tian B, Mei Y (2016) Nanowires and electrical stimulation synergistically improve functions of hIPSC cardiac spheroids. Nano Lett 16:4670–4678
Rogers JA, Someya T, Huang Y (2010) Materials and mechanics for stretchable electronics. Science 327:1603–1607
Rogozhnikov D, O’Brien PJ, Elahipanah S, Yousaf MN (2016) Scaffold free bio-orthogonal assembly of 3-dimensional cardiac tissue via cell surface engineering. Sci Rep 6:39806–39816
Saini H, Navaei A, Van Putten A, Nikkhah M (2015) 3D cardiac microtissues encapsulated with the co-culture of cardiomyocytes and cardiac fibroblasts. Adv Healthc Mater 4:1961–1971
Saric A, Andreau K, Armand AS, Moller IM, Petit PX (2016) Barth syndrome: from mitochondrial dysfunctions associated with aberrant production of reactive oxygen species to pluripotent stem cell studies. Front Genet 6:359–383
Schroer AK, Shotwell MS, Sidorov VY, Wikswo JP, Merryman WD (2017) I-Wire heart-on-a-chip II: biomechanical analysis of contractile, three-dimensional cardiomyocyte tissue constructs. Acta Biomater 48:79–87
Selimović S, Dokmeci MR, Khademhosseini A (2013) Organs-on-a-chip for drug discovery. Curr Opin Pharmacol 13:829–833
Serena E, Figallo E, Tandon N, Cannizzaro C, Gerecht S, Elvassore N, Vunjak-Novakovic G (2009) Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species. Exp Cell Res 315:3611–3619
Shimizu T, Yamato M, Isoi Y, Akutsu T, Setomaru T, Abe K, Kikuchi A, Umezu M, Okano T (2002) Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90:e40–e48
Shimizu T, Yamato M, Kikuchi A, Okano T (2003) Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 24:2309–2316
Shin SR, Zhang YS, Kim DJ, Manbohi A, Avci H, Silvestri A, Aleman J, Hu N, Kilic T, Keung W, Righi M, Assawes P, Alhadrami HA, Li RA, Dokmeci MR, Khademhosseini A (2016) Aptamer-based microfluidic electrochemical biosensor for monitoring cell-secreted trace cardiac biomarkers. Anal Chem 88:10019–10027
Sidorov VY, Samson PC, Sidorova TN, Davidson JM, Lim CC, Wikswo JP (2017) I-wire heart-on-a-chip I: three-dimensional cardiac tissue constructs for physiology and pharmacology. Acta Biomater 48:68–78
Simmons CS, Petzold BC, Pruitt BL (2012) Microsystems for biomimetic stimulation of cardiac cells. Lab Chip 12:3235–3248
Tanaka Y, Morishima K, Shimizu T, Kikuchi A, Yamato M, Okano T, Kitamori T (2007) Demonstration of a PDMS-based bio-microactuator using cultured cardiomyocytes to drive polymer micropillars. Lab Chip 6:230–235
Tandon N, Marsano A, Maidhof R, Numata K, Montouri-Sorrentino C, Cannizzaro C, Voldman J, Vunjak-Novakovic G (2010) Surface-patterned electrode bioreactor for electrical stimulation. Lab Chip 10:692–700
Tandon N, Marsano A, Maidhof R, Wan L, Park H, Vunjak-Novakovic G (2011) Optimization of electrical stimulation parameters for cardiac tissue engineering. J Tissue Eng Regen Med 5:e115–e125
Tomecka E, Wojasinski M, Jastrzebska E, Chudy M, Ciach T, Brzozka Z (2017) Poly(l-lactic acid) and polyurethane nanofibers fabricated by solution blow spinning as potential substrates for cardiac cell culture. Mater Sci Eng C Mater Biol Appl 75:305–316
Tomecka E, Zukowski K, Jastrzebska E, Chudy M, Brzozka Z (2018) Microsystem with micropillar array for three-(gel-embaded) and two-dimensional cardiac cell culture. Sensors Actuat B 254:973–983
Ugolini GS, Rasponi M, Pavesi A, Santoro R, Kamm R, Fiore GB, Pesce M, Soncini M (2016) On-chip assessment of human primary cardiac fibroblasts proliferative responses to uniaxial cyclic mechanical strain. Biotechnol Bioeng 113:859–869
Vacek TP, Metreveli N, Tyagi N, Vacek JC, Pagni S, Tyagi SC (2011) Electrical stimulation of cardiomyocytes activates mitochondrial matrix metalloproteinase causing electrical remodeling. Biochem Biophys Res Commun 404:762–766
Visone R, Gilardi M, Marsano A, Rasponi M, Bersini S, Moretti M (2016) Cardiac meets skeletal: what’s new in microfluidic models for muscle tissue engineering. Molecules 21:e1128–e1148
Wei P, Taylor R, Ding Z, Chung C, Abilez OJ, Higgs G, Pruitt BL, Ziaie B (2011) Stretchable microelectrode array using room-temperature liquid alloy interconnects. J Micromech Microeng 21:054015
Werdich AA, Lima EA, Ivanov B, Ges I, Anderson ME, Wikswo JP, Baudenbacher FJ (2004) A microfluidic device to confine a single cardiac myocyte in a sub-nanoliter volume on planar microelectrodes for extracellular potential recordings. Lab Chip 4:357–362
Xiao Y, Zhang B, Liu H, Miklas JW, Gagliardi M, Pahnke A, Thavandiran N, Sun Y, Simmons C, Keller G, Radisic M (2014) Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle. Lab Chip 14:869–882
Yan J, Huang Y, Chrisey DB (2013) Laser-assisted printing of alginate long tubes and annular constructs. Biofabrication 5:015002
Yu F, Zhao Y, Gu J, Quigley KL, Chi NC, Tai YC, Hsiai TK (2012) Flexible microelectrode arrays to interface epicardial electrical signals with intracardial calcium transients in zebrafish hearts. Biomed Microdevices 14:357–366
Yue T, Nakajima M, Takeuchi M, Hu C, Huang Q, Fukuda T (2014) On-chip self-assembly of cell embedded microstructures to vascular-like microtubes. Lab Chip 14:1151–1161
Zhang D, Shadrin IY, Lam J, Xian HQ, Snodgrass HR, Bursac N (2013a) Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 34:5813–5820
Zhang X, Wang Q, Gablaski B, Zhang X, Lucchesi P, Zhao Y (2013b) A microdevice for studying intercellular electromechanical transduction in adult cardiac myocytes. Lab Chip 13:3090–3097
Zhang X, Wang T, Wang P, Hu N (2016a) High-throughput assessment of drug cardiac safety using a high-speed impedance detection technology-based Heart-on-a-chip. Micromachines 7:122_1–122_9
Zhang YS, Arneri A, Bersini S, Shin SR, Zhu K, Goli-Malekabadi Z, Aleman J, Colosi C, Busignani F, Dell'Erba V, Bishop C, Shupe T, Demarchi D, Moretti M, Rasponi M, Dokmeci MR, Atala A, Khademhosseini A (2016b) Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip. Biomaterials 110:45–59
Zhang B, Montgomery M, Chamberlain MD, Ogawa S, Korolj A, Pahnke A, Wells LA, Masse S, Kim J, Reis L, Momen A, Nunes SS, Wheeler AR, Nanthakumar K, Keller G, Sefton MV, Radisic M (2016c) Biodegradable scaffold with built-in vasculature for organ-on-a-chip engineering and direct surgical anastomosis. Nat Mater 15:669–678
Zhang YS, Aleman J, Arneri A, Bersini S, Piraino F, Shin SR, Dokmeci MR, Khademhosseini A (2016d) From Cardiac Tissue Engineering to Heart-on-a-Chip: Beating Challenges. Biomed Mater 10:1–21
Zhang L, Xu MX, Yin QS, Zhu CY, Cheng XL, Ren YR, Zhuang PW, Zhang YJ, (2017) Screening, verification, and analysis of biomarkers for drug-induced cardiac toxicity in vitro based on RTCA coupled with PCR Array technology. Toxicol Lett 268:17–25
Zuchowska A, Kwiatkowski P, Jastrzebska E, Chudy M, Dybko A (2016) Adhesion of MRC 5 and A549 cells on poly(dimethylsiloxane) surface modified by proteins. Electrophoresis 37:536–544
Acknowledgements
This work was realized with the frame of project LIDER No. LIDER/026/573/L-4/12/NCBR/2013.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Bulka, M., Jastrzebska, E. (2018). Heart-on-a-chip Systems. In: Brzozka, Z., Jastrzebska, E. (eds) Cardiac Cell Culture Technologies. Springer, Cham. https://doi.org/10.1007/978-3-319-70685-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-70685-6_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-70684-9
Online ISBN: 978-3-319-70685-6
eBook Packages: EngineeringEngineering (R0)